Concord Biotech

1,989.75
+88.85
(4.67%)
Market Cap (₹ Cr.)
₹19,861
52 Week High
2,664.00
Book Value
₹146
52 Week Low
1,212.05
PE Ratio
60.56
PB Ratio
12.49
PE for Sector
37.21
PB for Sector
3.95
ROE
20.18 %
ROCE
26.63 %
Dividend Yield
0.46 %
EPS
₹29.94
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
18.26 %
Net Income Growth
28.33 %
Cash Flow Change
7.91 %
ROE
8.44 %
ROCE
24.26 %
EBITDA Margin (Avg.)
3.93 %

Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
189
165
250
285
201
270
249
330
226
320
Expenses
116
121
129
144
123
143
135
185
135
174
EBITDA
72
44
121
141
79
127
114
145
92
147
Operating Profit %
36 %
24 %
46 %
47 %
37 %
45 %
44 %
42 %
38 %
44 %
Depreciation
14
13
14
14
13
13
14
14
13
13
Interest
1
1
1
1
1
1
1
0
0
0
Profit Before Tax
58
30
106
126
65
113
100
131
78
133
Tax
14
8
26
31
16
28
26
30
19
34
Net Profit
43
22
79
94
48
84
75
97
58
99
EPS in ₹
4.12
2.15
7.56
8.94
4.63
8.08
7.13
9.29
5.57
9.43

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
763
941
1,183
1,313
1,515
1,699
Fixed Assets
230
240
546
573
593
575
Current Assets
500
539
607
633
728
896
Capital Work in Progress
19
141
18
74
173
211
Investments
229
199
142
74
138
244
Other Assets
285
361
477
592
611
668
Total Liabilities
81
170
183
206
223
174
Current Liabilities
54
115
106
152
191
142
Non Current Liabilities
27
55
77
54
32
32
Total Equity
683
770
1,000
1,107
1,292
1,525
Reserve & Surplus
673
761
990
1,098
1,282
1,515
Share Capital
10
10
10
10
10
10

Cash Flow

Cash Flow
2018
2020
2021
2022
2023
2024
Net Cash Flow
0
-1
3
-4
3
12
Investing Activities
-42
-114
-195
-112
-158
-155
Operating Activities
79
155
167
207
246
265
Financing Activities
-37
-43
31
-100
-85
-99

Share Holding

% Holding
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
44.08 %
44.08 %
44.08 %
44.08 %
44.08 %
44.08 %
FIIs
4.59 %
7.30 %
7.00 %
6.48 %
7.11 %
8.10 %
DIIs
5.41 %
8.18 %
8.46 %
8.46 %
10.40 %
9.89 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
45.92 %
40.44 %
40.46 %
40.97 %
38.41 %
37.93 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,777.65 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
1,464.40 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
2,533.00 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
1,194.00 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
945.30 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
2,042.50 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
1,220.85 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
5,595.60 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
1,466.75 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
1,572.75 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
52.16
ATR(14)
Less Volatile
81.60
STOCH(9,6)
Neutral
64.96
STOCH RSI(14)
Overbought
95.67
MACD(12,26)
Bullish
12.03
ADX(14)
Weak Trend
11.69
UO(9)
Bearish
49.78
ROC(12)
Uptrend And Accelerating
5.25
WillR(14)
Neutral
-25.64